AstraZeneca PLC
18 May 2000
DEALING BY DIRECTORS
COMPANIES ACT 1985 SECTIONS 324/329
WE HEREBY INFORM YOU THAT ON 17 MAY 2000 SIR DAVID BARNES, A
DIRECTOR OF THE COMPANY, EXERCISED AN OPTION OVER ASTRAZENECA
PLC USD0.25 ORDINARY SHARES UNDER THE COMPANY'S 1993 SENIOR
STAFF SHARE OPTION SCHEME. THE DETAILS OF THE EXERCISE ARE AS
FOLLOWS:-
NUMBER OF TOTAL
SHARES EXERCISE NUMBER OF
OVER WHICH PRICE SHARES NOW
NAME OF OPTION PER PERIOD WHEN UNDER
DIRECTOR EXERCISED SHARE EXERCISABLE OPTION
SIR DAVID 3,000 630p 24.6.96- 141,031
BARNES 23.6.03
SUBSEQUENT TO THE ACQUISITION OF 3,000 SHARES FOLLOWING THIS
EXERCISE, WE ALSO INFORM YOU THAT ON 17 MAY 2000, SIR DAVID
BARNES SOLD ASTRAZENECA PLC USD0.25 ORDINARY SHARES AS FOLLOWS:-
NUMBER OF PRICE TOTAL NUMBER PERCENTAGE
NAME OF SHARES PER OF SHARES NOW OF ISSUED
DIRECTOR SOLD SHARE HELD SHARES
SIR DAVID 704 2700p 216,851 0.012
BARNES
G H R MUSKER
COMPANY SECRETARY
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.